期刊文献+

射频消融后残余肿瘤模型的制作及病理观察

Establishment and pathological observation of rabbit remnant carcinoma models after RFA therapy
暂未订购
导出
摘要 目的观察兔VX2射频消融后残余肿瘤模型不同时间段病理形态学变化。方法超声引导经皮穿刺48只新西兰白兔接种VX2肿瘤,并开腹射频消融制作残余肿瘤模型。将模型随机分成6组,每组8只,分别于射频消融术(RFA)之前、术后1天、3天、1周、2周及3周观察病理学变化。结果残余肿瘤组织射频消融术后MVD、VEGF及PCNA表达即明显减低,一直维持较低水平至射频消融后2周;RFA后2周至第3周,MVD、VEGF及PCNA表达再次增加。结论射频消融治疗后残余肿瘤短期内受到抑制,仍需要进一步治疗。 Objective To establish rabbit model of remnant carcinoma after RFA therapy, and to observe pathomorphological changes of remnant carcinoma in different time. Methods Forty-eight New Zealand white rabbits underwent ultrasoundguided percutaneous inoculation with VX2 carcinoma, then RFA therapy was performed to made models of remnant carcinoma. These models were averagely divided into 6 groups randomly (each n=8). Rabbits in each group was killed and pathologically observed before RFA and 1 d, 3 d, 1 week, 2 and 3 weeks after operation, respectively. Results The expression of MVD,VEGF and PCNA in remnant VX2 carcinomas tissues decreased significantly, but increased 2-3 weeks after RFA. The remnant VX2 carcinomas tissues were in inhibitory state 2 weeks after RFA. Conclusion The growth of remnant carcinoma could be inhibited in short term after RFA. Further therapy is necessary.
出处 《中国医学影像技术》 CSCD 北大核心 2009年第10期1753-1756,共4页 Chinese Journal of Medical Imaging Technology
基金 黑龙江省科技厅青年基金(QC08C06) 黑龙江省教育厅科学技术研究(面上)项目计划(11541221)
关键词 导管消融 模型 动物 残余肿瘤 Catheter ablation Models, animal Remnant carcinoma
  • 相关文献

参考文献11

二级参考文献35

  • 1张建国,孙聚葆,陈殿森,周四维,史秋生.超声、CT、MRI对离体动物肾脏射频消融效果评估的价值[J].中国现代医学杂志,2005,15(22):3409-3412. 被引量:3
  • 2[1]De Baere T, Bessoud B, Dromain C, et al. Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. AJR,2000,175(6):1619-1625.
  • 3[2]Solbiatu L, Livraghi T, Goldberg SN, et al. Percutaneous radiofrequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology,2001,221(1):159-166.
  • 4[3]Curley SA, Izzo F, Ellis LM, et al. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg,2000,232(3):381-391.
  • 5[4]Goldberg SN, Gazelle GS, Solbiati L, et al. Radiofrequency tissue ablation: increased lesion diameter with a perfusion electrode. Acad Radiol,1996,3(7):636-644.
  • 6[5]Goldberg SN, Solbiati L, Hahn P, et al. Radiofrequency tumor ablation using a clustered electrode technique: results in animals and patients with liver metastases.Radiology,1998,209(2):371-379.
  • 7[6]McGahan JP, Weizhong G, Brock JM, et al. Hepatic ablation using bipolar radiofrequency electrocautery. Acad Radiol,1996,3(5):418-422.
  • 8[7]Yamasaki T, Kurokawa F, Shirahashi H, et al. Percutaneous radiofrequency ablation therapy for patients with hepatocellular carcinoma during occlusion of hepatic blood flow.Comparison with standard percutaneous radiofrequency ablation therapy. Cancer,2002,95(11):2353-2360.
  • 9[8]De Baere T, Bessoud B, Dromain C, et al. Percutaneous radiofrequency ablation of hepatic tumors during temporary venous occlusion. AJR,2002,178(1):53-59.
  • 10[9]Kettenbach J, Kostler W, Rucklinger E, et al. Percutaneous saline-enhanced radiofrequency ablation of unresectable hepatic tumors: initial experience in 26 Patients. AJR,2003,180(6):1537-1545.

共引文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部